Skip to main content

Table 3 Crude and adjusted association of T2D with amino acid profile quartiles

From: The association between dietary amino acid profile and the risk of type 2 diabetes: Ravansar non-communicable disease cohort study

Amino Acids

n case/control

Model I

Model II

Model III

OR (95% CI)

Branched-chain

 Q1

24/119

1.00

1.00

1.00

 Q2

28/112

1.23 (0.67-2.26)

1.55 (0.79-3.03)

1.91 (0.92-3.97)

 Q3

23/118

0.96 (0.51-1.80)

1.15 (0.57-2.33)

1.31 (0.58-2.94)

 Q4

38/103

1.82 (1.02-3.25)

1.90 (0.98-3.70)

2.70 (1.16-6.31)

Aromatic

 Q1

24/118

1.00

1.00

1.00

 Q2

27/114

1.16 (0.63-2.13)

1.30 (0.66-2.55)

1.59 (0.76-3.35)

 Q3

26/115

1.11 (0.60-2.04)

1.30 (0.65-2.59)

1.47 (0.66-3.28)

 Q4

36/105

1.68 (0.94-3.00)

1.67 (0.85-3.25)

2.36 (0.99-5.61)

Alkaline

 Q1

24/118

1.00

1.00

1.00

 Q2

26/115

1.11 (0.60-2.04)

1.39 (0.70-2.73)

1.59 (0.76-3.32)

 Q3

24/117

1.00 (0.54-1.87)

1.16 (0.58-2.32)

1.18 (0.52-2.66)

 Q4

39/102

1.87 (1.05-3.33)

1.92 (0.99-3.73)

2.68 (1.16-6.21)

Sulfuric

 Q1

23/119

1.00

1.00

1.00

 Q2

32/109

1.51 (0.83-2.75)

1.71 (0.88-3.31)

2.22 (1.08-4.56)

 Q3

21/120

0.90 (0.47-1.72)

1.07 (0.52-2.19)

1.20 (0.53-2.74)

 Q4

37/104

1.84 (1.02-3.29)

1.95 (0.99-3.83)

2.98 (1.27-6.96)

Acidic

 Q1

26/116

1.00

1.00

1.00

 Q2

23/118

0.86 (0.46-1.61)

0.97 (0.49-1.92)

1.09 (0.51-2.31)

 Q3

28/113

1.10 (0.61-2.00)

1.30 (0.66-2.54)

1.34 (0.61-2.94)

 Q4

36/105

1.52 (0.86-2.70)

1.43 (0.74-2.77)

1.80 (0.74-4.35)

Alcoholic

 Q1

24/118

1.00

1.00

1.00

 Q2

26/115

1.11 (0.60-2.04)

1.25 (0.63-2.45)

1.48 (0.70-3.11)

 Q3

27/114

1.16 (0.63-2.13)

1.37 (0.69-2.72)

1.64 (0.74-3.64)

 Q4

36/105

1.68 (0.94-3.00)

1.71 (0.87-3.34)

2.45 (1.02-5.90)

Small amino acids

 Q1

26/116

1.00

1.00

1.00

 Q2

23/118

0.86 (0.46-1.61)

1.00 (0.50-1.99)

1.15 (0.54-2.45)

 Q3

25/116

0.96 (0.52-1.76)

1.04 (0.53-2.04)

1.07 (0.48-2.39)

 Q4

39/102

1.70 (0.97-2.99)

1.67 (0.87-3.20)

2.16 (0.94-4.97)

Proline

 Q1

26/116

1.00

1.00

1.00

 Q2

26/115

1.00 (0.55-1.84)

1.13 (0.58-2.21)

1.22 (0.59-2.53)

 Q3

29/112

1.15 (0.64-2.08)

1.14 (0.58-2.22)

1.26 (0.58-2.74)

 Q4

32/109

1.30 (0.73-2.33)

1.37 (0.69-2.71)

1.67 (0.70-3.99)

Essential

 Q1

24/118

1.00

1.00

1.00

 Q2

30/111

1.32 (0.73-2.41)

1.66 (0.85-3.22)

2.05 (0.99-4.24)

 Q3

21/120

0.86 (0.45-1.62)

0.99 (0.48-2.01)

1.06 (0.46-2.42)

 Q4

38/103

1.81 (1.02-3.22)

1.90 (0.97-3.73)

2.66 (1.13-6.25)

Non-essential

 Q1

25/118

1.00

1.00

1.00

 Q2

25/115

1.02 (0.55-1.89)

1.16 (0.59-2.27)

1.36 (0.64-2.87)

 Q3

28/113

1.16 (0.64-2.12)

1.43 (0.73-2.82)

1.58 (0.71-3.50)

 Q4

35/106

1.55 (0.87-2.77)

1.45 (0.74-2.82)

1.89 (0.79-4.54)

  1. Model I: unadjusted model; Model II: adjusted for age, sex, residency (urban, rural), education, SES (poor, moderate and high), family history of diabetes, BMI, WHtR, and physical activity (MET) (low, moderate and high) and daily energy intake; Model III: adjusted for model II and sleep duration (<6 h, 6-7 h and ≥8 h), dietary patterns (healthy or unhealthy), comorbidities (yes or no), systolic and diastolic blood pressure